For ACCs, there was low immunogenic activity, showing low CD8+, GrB+ tumor-infiltrating lymphocytes, CD1a, and CD83 populations as well as scarce positivity for CTLA-4 and PD-1 [93]. This evidence concerns the gene PDCD1 and neoplasm.